Open-label Phase II Clinical Trial of Orteronel (TAK-700) in Metastatic or Advanced Non-Resectable Granulosa Cell Ovarian Tumors: the Greko II Study (GETHI2013-01)
Clinical and Translational Oncology（2024）
Key words
Granulosa cell ovarian tumors,Orteronel,Greko,Clinical trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined